ArticleBMJ open2024

Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration, 2010-2019: a cross-sectional analysis.

Matthew J Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.